FMH Specialist in Dermatology and Venereology

Dr Michael Benzaquen joined the medical team at Clinique La Prairie in 2023. Highest achiever in his year at the Faculty of Medicine in Marseilles, he completed all his medical training there before becoming Clinical Chief in Dermatology at the Hôpital Nord in Marseilles.

Since November 2019, he has been working as Clinical Chief in Dermatology at the Inselspital in Bern, a university hospital position which he still holds. He is now putting his experience in clinical research to good use at the Clinique La Prairie, with almost 40 international publications to his credit.


  • General dermatology
  • Skin cancer
  • Dermatological surgery
  • Dermatological lasers 


  • Federation of Swiss Doctors - Dermatology and Venereology
  • Inter-university diploma in Surgical Dermatology
  • Inter-university diploma in Aesthetic Dermatology, Cosmetology and Dermatological Lasers
  • Inter-university diploma in the Dermatological Manifestations of Systemic Diseases
  • ECFMG Certification from the United States Medical Licensing Examination


  • Faculty of Medicine of Marseilles, Aix-Marseilles University, France
  • Columbia University, New York City, USA

Spoken Languages

  • French
  • English
  • German


  • Member of the Swiss Society of Dermatology and Venereology
  • Member of the European Academy of Dermatology and Venereology
  • Vice-President of the Scientific Council of the French Society of Lasers in Dermatology
  • Member of the Surgical Group of the French Society of Dermatology
  • Coordinator of the “NextGen Dermatology” sessions of the IMCAS congresses


    • Laser-assisted hyaluronic acid delivery by fractional carbon dioxide laser in facial skin remodelling: a prospective randomized split face study in France. Lasers in Surgery and Medicine. 2021 Nov; 53(9): 1166-1172. Benzaquen M, Fongue J, Pauly V, Collet-Villette AM
    • Cutaneous shrinkage after surgical resection of facial skin tumors: a prospective study on 100 surgical specimens. Clinical and Experimental Dermatology. 2019 Nov; 44(8): 941-944. Benzaquen M, Bruneau S, Graillon N, Berbis J, Guyot L
    • Development and accuracy of an artificial intelligence algorithm for acne grading from smartphone photographs. Experimental Dermatology. 2019 Nov; 28: 1252-1257. Seité S, Khammari A, Benzaquen M, Moyal D, Dréno B
    • Combined treatment of hypertrophic and keloid scars with intra-lesional injection of corticosteroids and laser-assisted corticosteroid delivery. Dermatologic Therapy. 2019 Nov; 32(6): e13126. Benzaquen M, Collet-Villette AM, Delaporte E
    • Mucous membrane pemphigoid of the oral lichen type: a retrospective analysis of 16 cases, Journal of the European Academy of Dermatology and Venereology. 2019 May; 33(5): e205-e207. Benzaquen M, Suter VGA, Gschwend M, Feldmeyer L, Borradori L
    • Dipeptidyl peptidase-IV inhibitors, a risk factor for bullous pemphigoid. Retrospective multicenter case-control study in France and Switzerland, Journal of the American Academy of Dermatology. 2018 Jun; 78(6): 1090-1096. Benzaquen M, Borradori L, Berbis P, Cazzaniga S, Valero R, Richard MA, Feldmeyer L

    Related Services


    The Dermatology Center supports the detection and treatment of skin cancers and skin diseases, whether chronic or infectious skin diseases, acne, hypersensitivity diseases or sexually transmitted diseases.